These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7486632)

  • 1. The tolerability, pharmacokinetics and pharmacodynamics of increasing intravenous doses of 619C89, a novel compound for the acute treatment of stroke, in healthy volunteers.
    Mercer AJ; Lamb RJ; Hussein Z; Hobbiger S; Posner J
    Ann N Y Acad Sci; 1995 Sep; 765():324-6. PubMed ID: 7486632
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions.
    Hussein Z; Fraser IJ; Lees KR; Muir KW; Lunnon MW; Hobbiger SF; Posner J
    Br J Clin Pharmacol; 1996 Jun; 41(6):505-11. PubMed ID: 8799514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled ascending dose tolerance study of 619C89 in acute stroke.
    Muir KW; Lees KR; Hamilton SJ; George CF; Hobbiger SF; Lunnon MW
    Ann N Y Acad Sci; 1995 Sep; 765():328-9. PubMed ID: 7486634
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and tolerability of 619C89 after acute stroke.
    Muir KW; Hamilton SJ; Lunnon MW; Hobbiger S; Lees KR
    Cerebrovasc Dis; 1998; 8(1):31-7. PubMed ID: 9645979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.
    Muir KW; Lees KR
    Ann N Y Acad Sci; 1995 Sep; 765():315-6. PubMed ID: 7486627
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics and safety of a potential memory-enhancing compound, CL 275,838, in healthy male volunteers.
    Caccia S; Confalonieri S; Guiso G; Lucca U; Parma E; Guido M; Tettamanti M; Tiraboschi P; Spagnoli A
    J Clin Pharmacol; 1994 Jul; 34(7):748-53. PubMed ID: 7929869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke.
    Muir KW; Holzapfel L; Lees KR
    Cerebrovasc Dis; 2000; 10(6):431-6. PubMed ID: 11070372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects.
    Dieterle W; Mann J; Kutz K
    J Clin Pharmacol; 2004 Jan; 44(1):59-66. PubMed ID: 14681342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
    Kawaguchi K; Graham SH
    Brain Res; 1997 Feb; 749(1):131-4. PubMed ID: 9070637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
    Miceli JJ; Wilner KD; Swan SK; Tensfeldt TG
    J Clin Pharmacol; 2005 Jun; 45(6):620-30. PubMed ID: 15901743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.
    Marzo A; Dal Bo L; Monti NC; Crivelli F; Ismaili S; Caccia C; Cattaneo C; Fariello RG
    Pharmacol Res; 2004 Jul; 50(1):77-85. PubMed ID: 15082032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89.
    Stefani A; Hainsworth AH; Spadoni F; Bernardi G
    Br J Pharmacol; 1998 Nov; 125(5):1058-64. PubMed ID: 9846645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.
    Rongen GA; Smits P; Ver Donck K; Willemsen JJ; De Abreu RA; Van Belle H; Thien T
    J Clin Invest; 1995 Feb; 95(2):658-68. PubMed ID: 7860749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects.
    Wemer J; Cheng YF; Nilsson D; Reinholdsson I; Fransson B; Lanbeck Vallén K; Nyman L; Eriksson C; Björck S; Schulman S
    Curr Med Res Opin; 2006 Sep; 22(9):1813-23. PubMed ID: 16968585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats.
    Nicolazzo JA; Nguyen TT; Katneni K; Steuten JA; Smith G; Jarrott B; Callaway JK; Charman SA
    J Pharm Pharmacol; 2008 Feb; 60(2):171-8. PubMed ID: 18237464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose, randomized crossover comparisons of different-strength imatinib mesylate formulations in healthy Korean male subjects.
    Kim KA; Park SJ; Kim C; Park JY
    Clin Ther; 2013 Oct; 35(10):1595-602. PubMed ID: 24060561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects.
    Kim JW; Kim JR; Yi S; Shin KH; Shin HS; Yoon SH; Cho JY; Kim DH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2011 Nov; 33(11):1819-30. PubMed ID: 22047812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
    Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.